Found: 78
Select item for more details and to access through your institution.
Serum concentration of the CKD4/6 inhibitor abemaciclib, but not of creatinine, strongly predicts hematological adverse events in patients with breast cancer: a preliminary report.
- Published in:
- Investigational New Drugs, 2021, v. 39, n. 1, p. 272, doi. 10.1007/s10637-020-00994-3
- By:
- Publication type:
- Article
Phase I dose-escalating study of panobinostat (LBH589) Administered intravenously to Japanese patients with advanced solid tumors.
- Published in:
- Investigational New Drugs, 2012, v. 30, n. 5, p. 1950, doi. 10.1007/s10637-011-9751-0
- By:
- Publication type:
- Article
Cost-Effectiveness of Trastuzumab With or Without Chemotherapy as Adjuvant Therapy in HER2-Positive Elderly Breast Cancer Patients: A Randomized, Open-Label Clinical Trial, the RESPECT Trial.
- Published in:
- Clinical Drug Investigation, 2022, v. 42, n. 3, p. 253, doi. 10.1007/s40261-022-01124-y
- By:
- Publication type:
- Article
A phase I/II trial of intraoperative breast radiotherapy in an Asian population: 5-year results of local control and cosmetic outcome.
- Published in:
- Radiation Oncology, 2015, v. 10, n. 1, p. 1, doi. 10.1186/s13014-015-0469-6
- By:
- Publication type:
- Article
A phase I/II trial of intraoperative breast radiotherapy in an Asian population: 5-year results of local control and cosmetic outcome
- Published in:
- Radiation Oncology, 2015, v. 10, n. 1, p. 150, doi. 10.1186/s13014-015-0469-6
- By:
- Publication type:
- Article
A phase I/II trial of intraoperative breast radiotherapy in an Asian population: 5-year results of local control and cosmetic outcome.
- Published in:
- 2015
- By:
- Publication type:
- journal article
ASO Visual Abstract: The Absence of Cancer in the Location of a Breast Tissue Marker After Neoadjuvant Chemotherapy May Predict Pathological Complete Response with High Accuracy—Results from a Phase II Trial.
- Published in:
- 2023
- By:
- Publication type:
- Abstract
ASO Author Reflections: How Can We Eliminate Breast Surgery in Patients Who Achieved Clinical Complete Response After Neoadjuvant Chemotherapy?
- Published in:
- Annals of Surgical Oncology: An Oncology Journal for Surgeons, 2023, v. 30, n. 6, p. 3233, doi. 10.1245/s10434-023-13206-y
- By:
- Publication type:
- Article
The Absence of Cancer in the Location of a Breast Tissue Marker After Neoadjuvant Chemotherapy may Predict Pathological Complete Response with High Accuracy: Results from a Phase II Trial.
- Published in:
- Annals of Surgical Oncology: An Oncology Journal for Surgeons, 2023, v. 30, n. 6, p. 3224, doi. 10.1245/s10434-023-13199-8
- By:
- Publication type:
- Article
ASO Author Reflections: The Strengths and Weaknesses of Intraoperative Radiotherapy for Early Breast Cancer and Ipsilateral Tumor Recurrence.
- Published in:
- Annals of Surgical Oncology: An Oncology Journal for Surgeons, 2019, v. 26, p. 660, doi. 10.1245/s10434-019-07658-4
- By:
- Publication type:
- Article
Multicenter Phase II Study of Intraoperative Radiotherapy of Early Breast Cancer: Ipsilateral Tumor Recurrence.
- Published in:
- Annals of Surgical Oncology: An Oncology Journal for Surgeons, 2019, v. 26, n. 8, p. 2428, doi. 10.1245/s10434-019-07350-7
- By:
- Publication type:
- Article
Clinical benefit of post-trastuzumab deruxtecan treatment in patients with HER 2-positive unresectable or metastatic breast cancer: A single-institution retrospective observational study.
- Published in:
- Breast Cancer Research & Treatment, 2024, v. 207, n. 2, p. 253, doi. 10.1007/s10549-024-07367-x
- By:
- Publication type:
- Article
A phase II study of sequential treatment with anthracycline and taxane followed by eribulin in patients with HER2-negative, locally advanced breast cancer (JBCRG-17).
- Published in:
- Breast Cancer Research & Treatment, 2021, v. 190, n. 3, p. 425, doi. 10.1007/s10549-021-06396-0
- By:
- Publication type:
- Article
Impact of chemotherapy on cognitive functioning in older patients with HER2-positive breast cancer: a sub-study in the RESPECT trial.
- Published in:
- Breast Cancer Research & Treatment, 2021, v. 188, n. 3, p. 675, doi. 10.1007/s10549-021-06253-0
- By:
- Publication type:
- Article
Patient-reported outcomes and objective assessments with arm measurement and bioimpedance analysis for lymphedema among breast cancer survivors.
- Published in:
- Breast Cancer Research & Treatment, 2020, v. 179, n. 1, p. 91, doi. 10.1007/s10549-019-05443-1
- By:
- Publication type:
- Article
Occult breast cancer may originate from ectopic breast tissue present in axillary lymph nodes.
- Published in:
- Breast Cancer Research & Treatment, 2018, v. 172, n. 1, p. 1, doi. 10.1007/s10549-018-4898-4
- By:
- Publication type:
- Article
Durable complete response in HER2-positive breast cancer: a multicenter retrospective analysis.
- Published in:
- Breast Cancer Research & Treatment, 2018, v. 167, n. 1, p. 81, doi. 10.1007/s10549-017-4489-9
- By:
- Publication type:
- Article
Effects of ABCB1 and ABCG2 polymorphisms on the pharmacokinetics of abemaciclib.
- Published in:
- European Journal of Clinical Pharmacology, 2022, v. 78, n. 8, p. 1239, doi. 10.1007/s00228-022-03331-0
- By:
- Publication type:
- Article
Pilot trial of an electronic patient-reported outcome monitoring system in patients with metastatic breast cancer undergoing chemotherapy.
- Published in:
- Breast Cancer (13406868), 2024, v. 31, n. 2, p. 283, doi. 10.1007/s12282-023-01537-3
- By:
- Publication type:
- Article
The Japanese Breast Cancer Society Clinical Practice Guidelines for surgical treatment of breast cancer, 2022 edition.
- Published in:
- Breast Cancer (13406868), 2024, v. 31, n. 1, p. 1, doi. 10.1007/s12282-023-01510-0
- By:
- Publication type:
- Article
The frequency of low HER2 expression in breast cancer and a comparison of prognosis between patients with HER2-low and HER2-negative breast cancer by HR status.
- Published in:
- Breast Cancer (13406868), 2022, v. 29, n. 2, p. 234, doi. 10.1007/s12282-021-01303-3
- By:
- Publication type:
- Article
Impact of adjuvant endocrine therapy on prognosis in small hormone receptor-positive, HER2-negative early breast cancer.
- Published in:
- Breast Cancer (13406868), 2021, v. 28, n. 5, p. 1087, doi. 10.1007/s12282-021-01245-w
- By:
- Publication type:
- Article
Correction to: The Japanese Breast Cancer Society clinical practice guidelines for surgical treatment of breast cancer, 2018 edition.
- Published in:
- 2021
- By:
- Publication type:
- Correction Notice
Clinicopathological characteristics, practical treatments, prognosis, and clinical issues of older breast cancer patients in Japan.
- Published in:
- Breast Cancer (13406868), 2021, v. 28, n. 1, p. 1, doi. 10.1007/s12282-020-01188-8
- By:
- Publication type:
- Article
Effects of neoadjuvant chemotherapy on operative adverse events and chemotherapy and radiotherapy in patients undergoing immediate breast reconstruction.
- Published in:
- Breast Cancer (13406868), 2020, v. 27, n. 4, p. 716, doi. 10.1007/s12282-020-01065-4
- By:
- Publication type:
- Article
The Japanese Breast Cancer Society clinical practice guidelines for surgical treatment of breast cancer, 2018 edition.
- Published in:
- Breast Cancer (13406868), 2020, v. 27, n. 1, p. 4, doi. 10.1007/s12282-019-01030-w
- By:
- Publication type:
- Article
A randomized phase II study evaluating pyridoxine for the prevention of hand-foot syndrome associated with capecitabine therapy for advanced or metastatic breast cancer.
- Published in:
- Breast Cancer (13406868), 2018, v. 25, n. 6, p. 729, doi. 10.1007/s12282-018-0879-z
- By:
- Publication type:
- Article
Assessing residual cancer cells using MRI and US after preoperative chemotherapy in primary breast cancer to omit surgery.
- Published in:
- Breast Cancer (13406868), 2018, v. 25, n. 5, p. 583, doi. 10.1007/s12282-018-0856-6
- By:
- Publication type:
- Article
Feasibility study of contralateral risk-reducing mastectomy with breast reconstruction for breast cancer patients with BRCA mutations in Japan.
- Published in:
- Breast Cancer (13406868), 2018, v. 25, n. 5, p. 539, doi. 10.1007/s12282-018-0850-z
- By:
- Publication type:
- Article
Comparison of sentinel lymph node biopsy between invasive lobular carcinoma and invasive ductal carcinoma.
- Published in:
- Breast Cancer (13406868), 2018, v. 25, n. 5, p. 560, doi. 10.1007/s12282-018-0852-x
- By:
- Publication type:
- Article
Rainbow of KIBOU (ROK) study: a Breast Cancer Survivor Cohort in Japan.
- Published in:
- Breast Cancer (13406868), 2018, v. 25, n. 1, p. 60, doi. 10.1007/s12282-017-0784-x
- By:
- Publication type:
- Article
Pharmacogenetic association between GSTP1 genetic polymorphism and febrile neutropenia in Japanese patients with early breast cancer.
- Published in:
- Breast Cancer (13406868), 2016, v. 23, n. 2, p. 195, doi. 10.1007/s12282-014-0547-x
- By:
- Publication type:
- Article
Sentinel lymph node biopsy is not necessary in patients diagnosed with ductal carcinoma in situ of the breast by stereotactic vacuum-assisted biopsy.
- Published in:
- Breast Cancer (13406868), 2016, v. 23, n. 2, p. 190, doi. 10.1007/s12282-014-0546-y
- By:
- Publication type:
- Article
Feasibility of intraoperative radiation therapy for early breast cancer in Japan: a single-center pilot study and literature review.
- Published in:
- Breast Cancer (13406868), 2014, v. 21, n. 4, p. 415, doi. 10.1007/s12282-012-0412-8
- By:
- Publication type:
- Article
Phase I/II study of intraoperative radiotherapy for early breast cancer in Japan.
- Published in:
- Breast Cancer (13406868), 2012, v. 19, n. 4, p. 353, doi. 10.1007/s12282-011-0294-1
- By:
- Publication type:
- Article
Safety of adjuvant trastuzumab for HER-2-overexpressing elderly breast cancer patients: a multicenter cohort study.
- Published in:
- Breast Cancer (13406868), 2012, v. 19, n. 3, p. 253, doi. 10.1007/s12282-011-0270-9
- By:
- Publication type:
- Article
Clinical usefulness of high-dose toremifene in patients relapsed on treatment with an aromatase inhibitor.
- Published in:
- Breast Cancer (13406868), 2010, v. 17, n. 4, p. 254, doi. 10.1007/s12282-009-0148-2
- By:
- Publication type:
- Article
Comprehensive geriatric assessment in elderly breast cancer patients.
- Published in:
- Breast Cancer (13406868), 2010, v. 17, n. 3, p. 183, doi. 10.1007/s12282-009-0167-z
- By:
- Publication type:
- Article
Compression therapy using surgical gloves does not prevent paclitaxel-induced peripheral neuropathy: results from a double-blind phase 2 trial.
- Published in:
- 2021
- By:
- Publication type:
- journal article
A single-arm, phase 2 study of steroid-containing mouthwash for the prevention of everolimus-associated stomatitis in multiple tumor types.
- Published in:
- International Journal of Clinical Oncology, 2019, v. 24, n. 10, p. 1320, doi. 10.1007/s10147-019-01476-0
- By:
- Publication type:
- Article
Satisfaction survey on a preoperative explanation method using three-dimensional breast imaging for breast cancer patients considering breast-conserving surgery.
- Published in:
- Surgery Today, 2023, v. 53, n. 4, p. 476, doi. 10.1007/s00595-022-02592-7
- By:
- Publication type:
- Article
The overall survival of breast cancer patients without adjuvant therapy.
- Published in:
- Surgery Today, 2019, v. 49, n. 7, p. 610, doi. 10.1007/s00595-019-01775-z
- By:
- Publication type:
- Article
Prognostic importance of neuroendocrine differentiation in Japanese breast cancer patients.
- Published in:
- Surgery Today, 2010, v. 40, n. 9, p. 831, doi. 10.1007/s00595-009-4179-2
- By:
- Publication type:
- Article
Circulating tumor cells detection in tumor draining vein of breast cancer patients.
- Published in:
- Scientific Reports, 2019, v. 9, n. 1, p. N.PAG, doi. 10.1038/s41598-019-54839-y
- By:
- Publication type:
- Article
Presence of small residual malignant lesions in pathologic complete response after neo‐adjuvant chemotherapy in patients with breast cancer.
- Published in:
- Breast Journal, 2019, v. 25, n. 6, p. 1303, doi. 10.1111/tbj.13473
- By:
- Publication type:
- Article
Prediction of pathological margin status using preoperative contrast‐enhanced MRI in patients with early breast cancer who underwent skin‐sparing mastectomy.
- Published in:
- Breast Journal, 2019, v. 25, n. 2, p. 202, doi. 10.1111/tbj.13194
- By:
- Publication type:
- Article
Survival Outcomes of Retreatment with Trastuzumab and Cytotoxic Chemotherapy for HER2-Positive Recurrent Patients With Breast Cancer Who Had Been Treated with Neo/adjuvant Trastuzumab Plus Multidrug Chemotherapy: A Japanese Multicenter Observational Study
- Published in:
- Breast Cancer: Basic & Clinical Research, 2018, n. 12, p. 1, doi. 10.1177/1178223418786243
- By:
- Publication type:
- Article
Single-dose trastuzumab monotherapy achieved pathological complete response (pCR) in a patient with HER2-positive breast cancer: a case report.
- Published in:
- 2023
- By:
- Publication type:
- Case Study
Trastuzumab emtansine in the treatment of HER2-positive metastatic breast cancer in Japanese patients.
- Published in:
- Breast Cancer: Targets & Therapy, 2014, v. 6, p. 37, doi. 10.2147/bctt.s44047
- By:
- Publication type:
- Article
A phase I/II trial of intraoperative breast radiotherapy in an Asian population: 10-year results with critical evaluation.
- Published in:
- Journal of Radiation Research, 2020, v. 61, n. 4, p. 602, doi. 10.1093/jrr/rraa029
- By:
- Publication type:
- Article